Method for determining whether a compound is an insulin receptor kinase activator
US6528037B2 · kind B2 · utility
0Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2002 |
| Grant date | Mar 4, 2003 |
| Priority date | — |
| Expiry date | Apr 2, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for determining whether a compound is an insulin receptor kinase activator.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.